Efficacy and Safety of Dextenza Compared to Topical Fluorometholone in Patients With Ocular Rosacea
Status:
Not yet recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
To determine patient preference and treatment outcomes with an intracanalicular dexamethasone
(0.4mg) insert compared to a standard steroid drop regimen in the contralateral eye for the
treatment of ocular rosacea.